Evaluating the direct medical cost, drug utilization and expenditure for managing Parkinson’s disease: a costing study at a medical center in China

BACKGROUND: With long-term pharmacotherapy, Parkinson’s disease (PD) is expectedly to incur a significant healthcare burden. However, drug utilization and costing study is limited, so is the cost composition and its impact on resource allocation. This study took a healthcare provider’s perspective t...

Descripción completa

Detalles Bibliográficos
Autores principales: Yi, Zhan-Miao, Li, Xin-Ya, Wang, Yu-Bo, Wang, Rui-Lin, Ma, Qian-Cheng, Zhao, Rong-Sheng, Chen, Li-Chia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9011260/
https://www.ncbi.nlm.nih.gov/pubmed/35433954
http://dx.doi.org/10.21037/atm-22-1014

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9011260/
https://www.ncbi.nlm.nih.gov/pubmed/35433954
http://dx.doi.org/10.21037/atm-22-1014

Ejemplares similares